Netflix stock price jumps on Warner Bros exit — what to watch when markets reopen

March 1, 2026
Netflix stock price jumps on Warner Bros exit — what to watch when markets reopen

New York, March 1, 2026, 10:02 EST — Market closed.

  • Netflix shares rallied 13.8%, ending higher after the company exited the Warner Bros bidding war.
  • Rivals stepping into the fray with a leveraged mega-deal are about to trigger a $2.8 billion termination fee.
  • Now, investors are watching to see how Netflix handles its cash—and whether it keeps its discipline.

Netflix surged 13.77% to close at $96.24 on Friday, after the company dropped its pursuit of Warner Bros Discovery’s studio and streaming assets following a protracted battle.

The timing is key: Netflix’s shares had been under pressure since early December, right after it landed that Warner Bros deal and investors began to speculate about potential debt loads. Now, with the deal unwinding, the company pockets a hefty fee and sidesteps any messy integration—just as big media players are chasing even more scale.

This move shakes up the landscape. Paramount Skydance is set to acquire Warner Bros Discovery for $110 billion, aiming for a beefed-up content library and sharper cost discipline to take on Netflix in streaming.

Netflix has decided against increasing its $27.75-per-share offer for Paramount, saying in a regulatory filing that matching Paramount’s $31-per-share bid is “no longer financially attractive,” Reuters reported.

Quilter Cheviot’s Ben Barringer called the move “a tick in the box” for discipline, saying investors are looking for management teams that “don’t overpay,” according to Reuters.

Reuters reports that Paramount covered a $2.8 billion termination fee for Warner Bros, leaving Netflix with the cash. That windfall could boost buybacks, fund new content, or do a bit of both—no need for Netflix to chase fresh deal risk.

Monday puts traders on alert: they’ll gauge the market’s view of a leaner balance sheet against the backdrop of a bigger competitor brewing, as Paramount’s deal waits for regulatory and political review under an antitrust lens.

Netflix bulls face the risk that Friday’s relief rally fizzles out—especially if a Paramount-Warner deal gains traction sooner than anticipated, or if investors write off the fee as a one-off, shifting focus to more concrete growth and spending signals.

Up next: management’s messaging. Netflix noted that CFO Spence Neumann is set for a Q&A slot at the Morgan Stanley Technology, Media & Telecom Conference on March 4, 4:50 p.m. Eastern. Investors tend to zero in here when it comes to guidance and capital plans.

Technology News Today

  • UT Austin researchers develop compact CRISPR nuclease for in-body genome editing
    April 13, 2026, 3:55 PM EDT. UT Austin researchers, funded by the NIH and working with Metagenomi Therapeutics, have identified and engineered a compact CRISPR nuclease, Al3Cas12f, that fits into viral delivery systems. The team began from a naturally occurring Cas12f enzyme, 400-700 amino acids long, which could navigate the payload limits of AAV vectors used to deliver gene-editing instructions. Their engineered variant shows improved performance in human cells and outperforms two other Cas12f enzymes previously tested in mice. The work, described in Nature Structural & Molecular Biology, used cryo-electron microscopy and machine learning to reveal mechanistic features that explain efficiency differences, guiding rational design of even better, compact nucleases for potential therapeutic development.